Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...

Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

President Trump has placed an indefinite suspension on research grant reviews and travel at the National Institutes of Health ...

As part of the second Trump Administration's diversity witchhunt, cancer research and other crucial projects have been paused ...

Trump has frozen all travel and communications at the Department of Health and Human Services, including the CDC and the ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.

The University of Nebraska said it was waiting for more information about what a pause in activities at the National ...